Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer
by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r
Updated on: May 23,2024
5

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer
by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r
Updated on:May 23,2024
5
